An interventional study of Transcutaneous Electrical Nerve Stimulation (TENS) in Hysterectomy, sponsored by Inonu University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by Inonu University · Not applicable, Interventional, and Treatment
This randomized controlled trial evaluated the effects of transcutaneous electrical nerve stimulation (TENS) on mobility, anxiety, and quality of recovery in women undergoing hysterectomy.
Participants were assigned to either an intervention group receiving TENS in addition to routine postoperative care or a control group receiving routine postoperative care alone. In the intervention group, TENS was administered in two 20-minute sessions during the early postoperative period.
Patient mobility, observer-rated mobility, anxiety, and quality of recovery were assessed using standardized measurement instruments.
The study aimed to determine whether adding TENS to routine postoperative care could improve early postoperative mobility, reduce anxiety, and enhance recovery quality following hysterectomy.
Hysterectomy is a common gynecological surgical procedure. During the early postoperative period, patients may experience difficulties with mobilization, anxiety, and reduced quality of recovery. Non-pharmacological interventions that support postoperative recovery are therefore clinically relevant.
This study was designed as a randomized controlled trial to investigate the effects of transcutaneous electrical nerve stimulation (TENS) on postoperative mobility, anxiety, and quality of recovery in women undergoing hysterectomy.
Participants were allocated to an intervention group or a control group. The intervention group received TENS in addition to routine postoperative care, while the control group received routine postoperative care.
TENS was administered during two sessions, approximately 5-6 hours and 13-14 hours after surgery. Each session lasted 20 minutes. Stimulation was delivered at a frequency of 100 Hz, with a pulse duration of 40-60 microseconds. Four electrodes were positioned around the surgical incision.
Postoperative mobility was evaluated using patient- and observer-rated mobility measures. Anxiety was assessed using an anxiety assessment scale, and quality of recovery was measured using the Quality of Recovery-40 (QoR-40) questionnaire.
The study investigated whether TENS could serve as a supportive, non-pharmacological intervention during early recovery following hysterectomy.
Inonu University is the lead sponsor of 394 studies on the registry; 95 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:- Women aged 18 years and over,
Exclusion Criteria:- Women with open wounds, infected areas or severe dermatological lesions,
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in the intervention group received transcutaneous electrical nerve stimulation (TENS) in addition to routine postoperative care following hysterectomy. TENS was administered in two 20-minute sessions at 5-6 and 13-14 hours after surgery. Kopyala
Device: Transcutaneous Electrical Nerve Stimulation (TENS)
Participants in the control group received routine postoperative care following hysterectomy. No transcutaneous electrical nerve stimulation (TENS) was administered. Participants underwent the same scheduled outcome assessments as the experimental group.
Participants received transcutaneous electrical nerve stimulation (TENS) using a Globus device in addition to routine postoperative care. TENS was administered in two 20-minute sessions at 5-6 and 13-14 hours after hysterectomy. The stimulation frequency was 100 Hz, with a pulse duration of 40-60 microseconds. Four electrodes were placed transversely, approximately 2 cm above and below the surgical incision.v
Patient Mobility Scale
The Patient Mobility Scale assesses patients' perceived difficulty during four postoperative mobility activities. Each activity is rated using a 15-cm visual analogue scale. Higher scores indicate greater difficulty with mobility.
Time frame: Postoperatively, immediately before and after each TENS session at 5-6 and 13-14 hours after surgery (four assessments).
Observer Mobility Scale (OMS)
The Observer Mobility Scale assesses the patient's level of independence during four postoperative mobility activities. Each activity is scored from 1 to 5. The total score ranges from 4 to 20, with higher scores indicating greater dependence and difficulty performing mobility activities.
Time frame: Postoperatively, immediately before and after each TENS session at 5-6 and 13-14 hours after surgery (four assessments).
Anxiety Assessment Scale (AAS)
The Anxiety Assessment Scale consists of 10 items across three dimensions: physiological tension, worry, and lack of security. The total score ranges from 10 to 50, with higher scores indicating higher levels of anxiety.
Time frame: Postoperatively, immediately before and after each TENS session at 5-6 and 13-14 hours after surgery (four assessments).
Quality of Recovery-40 (QoR-40)
The Quality of Recovery-40 questionnaire consists of 40 items covering five dimensions: physical comfort, emotional state, patient support, physical independence, and pain. Total scores range from 40 to 200, with higher scores indicating better postoperative recovery quality.
Time frame: Postoperatively, immediately before and after each TENS session at 5-6 and 13-14 hours after surgery (four assessments).
Plan to share: No — Individual participant data will not be shared publicly due to participant confidentiality and privacy considerations. There is no established plan for sharing de-identified individual participant data with other researchers.
Ran from Apr 2026 to primary completion in Aug 2026, 4 months.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.